As part of its advocacy program in the United States, ACRO submits regulatory comments to US regulators. This comment letter, submitted by ACRO to the U.S. Congress in March 2022 about the House Energy & Commerce Subcommittee on Health Hearing on “The Future of Medicine: Legislation to Encourage Innovation and Improve Oversight”.